Aligos Therapeutics Inc

ALGS NASDAQ Santé & Biotech États-Unis US01626L1052
5.30 $
3.81 %

Aligos Therapeutics est une entreprise biopharmaceutique qui développe des thérapies pour traiter des maladies virales et hépatiques.

Performance & Momentum

6 Months 47.42 %
1 Year 15.66 %
3 Years 81.39 %
5 Years 99.27 %

Similar stocks to Aligos Therapeutics Inc

Anantys Community

Be the first to share your analysis on Aligos Therapeutics Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases